SCHEMBL1126856

SCHEMBL1126856

Cc1c(F)cccc1[N+](=O)[O-]

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.72
TSHR P16473 3/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
HSD17B10 Q99714 1/20 0.52
GPR35 Q9HC97 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
NPC1 O15118 1/20 0.47
MAPT P10636 1/20 0.47
MAPK1 P28482 1/20 0.47
POLB P06746 2/20 0.45
KMT2A Q03164 2/20 0.44
LMNA P02545 1/20 0.44
GLA P06280 1/20 0.44
ALDH1A1 P00352 4/20 0.44
MEN1 O00255 1/20 0.44
ATM Q13315 1/20 0.44
HSPB1 P04792 1/20 0.44
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30563091 1.00 TDP1 (0.72) TDP1TSHRSMN1; SMN2HSD17B10GPR35
SCHEMBL472112 0.84 TDP1 (1.00) TDP1TSHRSMN1; SMN2HSD17B10GPR35
SCHEMBL1424697 0.81 TDP1 (0.56) TDP1TSHRSMN1; SMN2HSD17B10L3MBTL1
SCHEMBL29788829 0.81 TDP1 (0.56) TDP1TSHRSMN1; SMN2HSD17B10L3MBTL1
SCHEMBL4057047 0.79 MAPK1 (0.54) TDP1TSHRSMN1; SMN2HSD17B10L3MBTL1
SCHEMBL29355089 0.78 TDP1 (0.54) TDP1TSHRSMN1; SMN2HSD17B10GPR35
SCHEMBL29538967 0.78 TSHR (1.00) TDP1TSHRSMN1; SMN2HSD17B10GPR35
SCHEMBL307855 0.78 TDP1 (0.54) TDP1TSHRSMN1; SMN2HSD17B10GPR35
SCHEMBL9550119 0.78 TDP1 (0.78) TDP1TSHRSMN1; SMN2HSD17B10GPR35
SCHEMBL700469 0.78 TSHR (1.00) TDP1TSHRSMN1; SMN2HSD17B10GPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115260037-A Preparation method of 2-methyl-3-nitrobenzyl ether 西安拓超生物科技有限公司 2022-11-01 CN claimed
CN-111995577-A Synthetic method of 4-fluoro indazole 3-carbonitrile or derivatives thereof 上海代为化学科技有限公司 2020-11-27 CN claimed
CN-106854172-B A kind of preparation method of the fluoro- 1H- indoles -4- methyl formate of 6- 山东轩德医药科技有限公司 2019-04-19 CN claimed
CN-103420892-A Preparation method of 4-fluoroindole ASCEPION PHARMACEUTICALS INC 2013-12-04 CN claimed
EP-1493061-A4 POLYMERIC ANTIREFLECTIVE COATINGS DEPOSITED BY PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION BREWER SCIENCE INC (US) 2009-01-07 EP claimed
US-7132219-B2 Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition BREWER SCIENCE INC. (US) 2006-11-07 US claimed
EP-1493061-A2 POLYMERIC ANTIREFLECTIVE COATINGS DEPOSITED BY PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION Brewer Science, Inc. (US) 2005-01-05 EP claimed
US-20030219541-A1 Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition BREWER SCIENCE, INC. 2003-11-27 US claimed
WO-2003087233-A2 POLYMERIC ANTIREFLECTIVE COATINGS DEPOSITED BY PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION BREWER SCIENCE, INC. (US) 2003-10-23 WO claimed
CN-121198652-A Water washing device for 2-fluoro-6-nitrotoluene production 江苏永创医药科技股份有限公司 2025-12-26 CN disclosed
CN-121198652-A Water washing device for 2-fluoro-6-nitrotoluene production 江苏永创医药科技股份有限公司 2025-12-26 CN disclosed
EP-3958865-B1 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES BAYER AG (DE) 2025-12-10 EP disclosed
US-12403135-B2 4H-pyrrolo[3,2-c]pyridin-4-one derivatives BAYER AKTIENGESELLSCHAFT (DE) 2025-09-02 US disclosed
US-12378202-B2 Tetrahydrobenzoazepinones and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2025-08-05 US disclosed
EP-0027214-A1 Imidazodiazepine derivatives, process and intermediates for their preparation, medicaments containing them and their therapeutic application F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-04-22 EP disclosed
US-4224340-A Anti-inflammatory compositions containing α-phenyl-N-phenylnitrone compounds WILLIAM H. RORER, INC. (US) 1980-09-23 US disclosed
US-4214003-A ANTIINFLAMMATORY AGENTS WILLIAM H. RORER, INC. (US) 1980-07-22 US disclosed
US-4197314-A WITH A DIPHENYL NITRONE WILLIAM H. RORER, INC. (US) 1980-04-08 US disclosed
US-4153722-A ANTIINFLAMMATORY, A-PHENYL-N-PHENYLNITRONE WILLIAM H. RORER, INC. (US) 1979-05-08 US disclosed
US-3932407-A BRONCHODILATORS, HYPOTENSIVE AGENTS, ANTICOAGULANTS BRISTOL-MYERS COMPANY (US) 1976-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12403135-B2 4H-pyrrolo[3,2-c]pyridin-4-one derivatives EGFR, ERBB2, ERBB4 TDP1 1060/4885TSHR 2270/4885SMN1; SMN2 1682/4885
US-12378202-B2 Tetrahydrobenzoazepinones and related analogs for inhibiting YAP/TAZ-TEAD YAP1, TEAD2, TEAD4 TDP1 2257/4885TSHR 2736/4885SMN1; SMN2 3403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.